ph011-advanced-drug-delivery-systems-a-global-market-overview

Advanced Drug Delivery Systems – A Global Market Overview

Published Date: Aug 2018

Report Code: PH011

Pages:422

Charts:297

Report Synopsis
Pharmaceutical companies have developed numerous therapeutic compounds that can address several life threatening ailments or disorders. The traditional dosage form offers spontaneous drug liberation that leads to drug concentration variation in the circulatory system. Hence to regulate the steady effective drug levels in the blood, introduction of Advanced Drug Delivery System is essential.

Availability of the therapeutic compounds that are site specific, exhibit maximum therapeutic efficacy, capable of performing the same action in minimal dosage forms, increase in research and development protocols that aim to introduce maximum number of advanced drug delivery systems are some of the factors responsible for the growth of Advanced Drug Delivery Systems market.

global advanced drug delivery systems market

Research Findings & Coverage

  • Global Advanced Drug Delivery Systems market is analyzed in this report with respect to carrier types, route of administration and applications
  • Degradable Microneedle - Promising Future Injectable Drug Delivery System
  • Electrospun Based Nanofibers – A Novel Drug Delivery System
  • Reduction-Sensitive Polymer Nanomedicines - Future Targeted Drug Delivery Platform for Cancer
  • Platelets Serving as a Novel Drug Carrier
  • Key business trends focusing on product innovations/developments, M&As, JVs and other recent industry developments
  • Major companies profiled – 39
  • The industry guide includes the contact details for 204 companies

Product Outline
The report analyzes the market for the following carrier types of Advanced Drug Delivery Systems:

  • Nanoparticles
  • Polymers
  • Monoclonal Antibodies
  • Others (includes Prodrugs, Microparticles etc.)

Advanced Drug Delivery Systems market, in terms of Route of Administration, analyzed in this report include the following:

  • Oral
  • Parenteral
  • Topical
  • Others (includes Rectal, Nasal, Implants etc.)

The study explores the market for Advanced Drug Delivery Systems applications comprises:

  • Oncology
  • Cardiology
  • Neurology
  • Pulmonary
  • Other Applications (includes Diabetes, Ophthalmology, Gastrointestinal disorders, Urology etc.)

Analysis Period, Units and Growth Rates

  • The report reviews, analyzes and projects the global Advanced Drug Delivery Systems market for the period 2015-2024 in terms of value in US$ and the compound annual growth rates (CAGRs) projected from 2017 through 2024

Geographic Coverage

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, Italy, Spain, The United Kingdom and Rest of Europe)
  • Asia-Pacific (China, India, Japan, South Korea and Rest of APAC)
  • Rest of World (Brazil, South Africa and Other)

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION
1.1 Product Outline
1.1.1 Drug Delivery
1.1.1.1 Conventional Dosage Forms
1.1.1.1.1 Advantages of Conventional Dosage Forms
1.1.1.1.2 Disadvantages of Conventional Dosage Forms
1.1.1.2 Modified Release Drug Delivery System
1.1.1.2.1 Modified drug delivery systems Benefits include
1.1.1.2.2 Types of Non immediate Release Dosage Forms
1.1.2 Advanced Drug Delivery Systems
1.1.2.1 Advantages of Advanced Drug Delivery Systems over Conventional Systems
1.1.2.2 Carrier Types
1.1.2.2.1 Liposomes
1.1.2.2.2 Nanogels
1.1.2.2.3 Polymers
1.1.2.2.4 Monoclonal Antibodies
1.1.2.2.4.1 Antibody Drug Conjugates
1.1.2.2.5 Prodrugs
1.1.2.2.6 Albumin
1.1.2.2.7 Niosomes
1.1.2.2.8 Microparticles
1.1.2.3 Route of Administration
1.1.2.3.1 Oral Drug Delivery Systems
1.1.2.3.1.1 Chewing Gums
1.1.2.3.2 Parenteral Drug Delivery Systems
1.1.2.3.2.1 Needle Free Injection Technology
1.1.2.3.2.2 Autoinjector
1.1.2.3.3 Topical Drug Delivery System
1.1.2.3.3.1 Methods Employed To Improve the Topical Administration of Drug
1.1.2.3.4 Transdermal Patches
1.1.2.3.5 Implants
1.1.2.3.6 Nasal Drug Delivery
1.1.2.4 Advanced Drug Delivery Systems Applications
1.1.2.4.1 Oncology
1.1.2.4.1.1 Lipoprotein
1.1.2.4.1.2 Nanoparticles
1.1.2.4.1.3 Nanoemulsions
1.1.2.4.1.4 Microcapsules
1.1.2.4.1.5 Microemulsion
1.1.2.4.1.6 Microspheres
1.1.2.4.1.7 Dendrimers
1.1.2.4.2 Cardiovascular Diseases
1.1.2.4.3 Glaucoma
1.1.2.4.4 Multiple Sclerosis
1.1.2.4.5 Malaria Treatment
1.1.2.4.6 Research and Development
1.1.2.4.7 Tissue or Organ Transplantation
1.1.2.4.8 Gastrointestinal Disorder
1.1.2.4.9 Central Nervous Systems Ailments
1.1.2.4.10 Diabetes
1.1.2.4.11 Periodontal Diseases

2. KEY MARKET TRENDS
2.1 Self Fabricating Nanotubes – Potential Advanced Drug Delivery Channels
2.2 Sperm Tagged Drug as Advanced Drug Carrier to Treat Female Reproductive Ailments
2.3 Fluid Feeding Insects as a Replica to Design Advanced Drug Delivery Systems
2.4 Degradable Microneedle – Promising Future Injectable Drug Delivery System
2.5 Nanoparticles based Nasal Spray for Brain Disorders
2.6 Electrospun based Nanofibers – A Novel Drug Delivery System
2.7 Reduction-Sensitive Polymer Nanomedicines - Future Targeted Drug Delivery Platform for Cancer
2.8 Platelets Serving as a Novel Drug Carrier
2.9 Biomaterial Matrix as Growth Factors Carriers in Wound Healing Protocols
2.10 Anhydrous Nanoemulsions Acts as a Vehicle to Delivery Less Water Dissolvable Therapeutic Compounds
2.11 Nano and Micro Needles as an Advanced Transepidermal Drug Carrier

3. KEY GLOBAL PLAYERS
3M Company (United States)
Adare Pharmaceuticals, Inc (United States)
Alkermes, Inc. (Ireland)
Astrazeneca PLC (United Kingdom)
Bayer AG (Germany)
Becton, Dickinson and Company (United States)
Capsugel, Inc. (United States)
Catalent, Inc. (United States)
Consort Medical PLC (United Kingdom)
Bespak Europe Ltd (United Kingdom)
Elixir Medical Corporation (United States)
Gerresheimer AG (Germany)
Sensile Medical AG (Switzerland)
Hisamitsu Pharmaceutical Co., Inc. (Japan)
HNS International, Inc. (United States)
Insulet Corporation (United States)
Lupin Ltd (India)
Nektar Therapeutics (United States)
Novavax, Inc. (United States)
SHL Group (Taiwan)

4. KEY BUSINESS & PRODUCT TRENDS
Omnipod® System Now Available in British Columbia
Mundipharma and PharmaJet Join Forces to Distribute Needle Free Drug Delivery System
Introduction of Non Patented Exelon® patch by Mylan
InsuJet Plans to Directly Distribute Omnipod® Product portfolio in Europe
Release of KP415.E01 Efficacy and Safety Outcomes in ADHD Children by Kempharma
Successful Completion of Treprostinil Technosphere’s phase I studies against PAH by Mannkind
Breakthrough Therapy Designation Honored to HTX-011 of Heron by FDA
SELFDOSETM injector of West Receives Silver MDEA
Establishment of Novel Alliances in Europe to Extend the Omnipod systems Availability
Ferring Paid Third Partial Payment for ZOMAJET to Antares
Indian Supply Contract signed between Mannkind and Cipla for Afrezza
MED TRUST and Valeritas signed a V-Go® Supply Contract in Germany and Austria
Presentation of RSV F and NanoFlu™ Vaccines Clinical Data at World Vaccine Congress by Novavax
Valeritas signed a contract to Supply V-Go in Australia and New Zealand with AMSL Diabetes and NZMS
PharmaJet Announces Positive Outcomes for Phase I Hantavirus Vaccine Clinical Studies
Harvard and Novartis Joins Forces to Design Immunotherapy Drug Delivery System
Orphan Drug Status Allotted to ZENEO to treat Status Epilepticus
Movi SpA and Valeritas Entered into V-Go Italian Marketing Deal
Genexine and PharmaJet Join Forces to Develop DNA Vaccine
Expansion of HPV vaccine Human Clinical Studies by Vaccibody
FDA Clearance Granted to Kempharm’s Apadaz
V-Go of Valeritas is Accessible in Puerto Rico Through Fusion Consulting Group
Invectys Initiates DNA Cancer Vaccine Phase II Studies in Association with PharmaJet®
CINVANTITM of Heron Receives U.S. FDA Clearance for CINV
Elixir Introduces DynamXTM Stent
Lonza Emerges as a Major Integrated Solution Providing Entity after Acquiring Capsugel
Catalent Join Forces with Rutgers for Pediatric Drug Formulation and Delivery
Introduction of Needle Free MMR Vaccine by PharmaJet and Serum Institute
SUSTOL® of Heron Adopted in NCCN Antiemesis Guidelines
3M and Panacea Join Forces to Develop Novel Cancer Vaccine
Emergence of Avadel by the completion of Cross-Border Merger of Flamel
Bayer Partners with DelSiTech to Develop Ophthalmic Drug
PharmaJet Develops HPV Vaccine in Association with Vaccibody
SUSTOLTM of Heron Received U.S FDA Clearance to Treat Chemotherapy Related Nausea & Vomiting
Utilization of PharmaJet Device against Zika Virus by NIH
PharmaJet Signs a Multiyear Contract with WHO for Polio
PharmaJet Unites with Universities to Offer Needle-Less Flu Shots
Amgen Opts SmartDose Drug Delivery System of West for PushtronexTM
ELIGARD of TOLMAR Achieves FDA Clearance to store at Room Temperature Up To 56 Days
Launch of Novel Transdermal Release Line by 3M
Consort by acquiring Aesica Introduces a Novel Trade Name
AstraZeneca Employs DEP drug delivery platform of Starpharma for Cancer Drug

5. GLOBAL MARKET OVERVIEW
5.1 Global Advanced Drug Delivery Systems Market Overview by Carrier Type
5.1.1 Global Advanced Drug Delivery systems Carrier Type Market Overview by Geographic Region
5.1.1.1 Nanoparticles
5.1.1.2 Polymers
5.1.1.3 Monoclonal Antibodies
5.1.1.4 Other Carrier Types
5.2 Global Advanced Drug Delivery Systems Market Overview by Route of Administration
5.2.1 Global Advanced Drug Delivery systems Route of Administration Market Overview by Geographic Region
5.2.1.1 Oral
5.2.1.2 Parenteral
5.2.1.3 Topical
5.2.1.4 Other Routes of Administration
5.3 Global Advanced Drug Delivery Systems Market Overview by Application
5.3.1 Global Advanced Drug Delivery Systems Application Market Overview by Geographic Region
5.3.1.1 Oncology
5.3.1.2 Cardiology
5.3.1.3 Neurology
5.3.1.4 Pulmonary
5.3.1.5 Other Applications

PART B: REGIONAL MARKET PERSPECTIVE

REGIONAL MARKET OVERVIEW

6. NORTH AMERICA
6.1 North American Advanced Drug Delivery Systems Market Overview by Geographic Region
6.2 North American Advanced Drug Delivery Systems Market Overview by Carrier Type
6.2.1 North American Advanced Drug Delivery systems Carrier Type Market Overview by Geographic Region
6.2.1.1 Nanoparticles
6.2.1.2 Polymers
6.2.1.3 Monoclonal Antibodies
6.2.1.4 Other Carrier Types
6.3 North American Advanced Drug Delivery Systems Market Overview by Route of Administration
6.3.1 North American Advanced Drug Delivery systems Route of Administration Market Overview by Geographic Region
6.3.1.1 Oral
6.3.1.2 Parenteral
6.3.1.3 Topical
6.3.1.4 Other Routes of Administration
6.4 North American Advanced Drug Delivery Systems Market Overview by Application
6.4.1 North American Advanced Drug Delivery Systems Application Market Overview by Geographic Region
6.4.1.1 Oncology
6.4.1.2 Cardiology
6.4.1.3 Neurology
6.4.1.4 Pulmonary
6.4.1.5 Other Applications
6.5 Major Market Players
3M Company (United States)
Adare Pharmaceuticals, Inc (United States)
Becton, Dickinson and Company (United States)
Capsugel, Inc. (United States)
Catalent, Inc. (United States)
Elixir Medical Corporation (United States)
Eyepoint Pharmaceuticals, Inc. (United States)
Heron Therapeutics, Inc. (United States)
HNS International, Inc. (United States)
Insulet Corporation (United States)
Kempharm, Inc. (United States)
Mannkind Corporation (United States)
Medical International Technologies (Mit Canada) Inc. (Canada)
Mylan Laboratories (United States)
National Medical Products, Inc. (United States)
Nektar Therapeutics (United States)
Novavax, Inc. (United States)
Noven Pharmaceuticals, Inc. (United States)
Pharmajet (United States)
Theraject, Inc. (United States)
Tolmar Pharmaceuticals, Inc. (United States)
Valeritas, Inc. (United States)
West Pharmaceutical Services, Inc. (United States)
Xel Pharmaceuticals, Inc. (United States)

6.6 Country-wise Analysis of North American Advanced Drug Delivery Systems Market
6.6.1 The United States
6.6.1.1 United States Advanced Drug Delivery Systems Market Overview by Carrier Type
6.6.1.2 United States Advanced Drug Delivery Systems Market Overview by Route of Administration
6.6.1.3 United States Advanced Drug Delivery Systems Market Overview by Application

6.6.2 Canada
6.6.2.1 Canadian Advanced Drug Delivery Systems Market Overview by Carrier Type
6.6.2.2 Canadian Advanced Drug Delivery Systems Market Overview by Route of Administration
6.6.2.3 Canadian Advanced Drug Delivery Systems Market Overview by Application

6.6.3 Mexico
6.6.3.1 Mexican Advanced Drug Delivery Systems Market Overview by Carrier Type
6.6.3.2 Mexican Advanced Drug Delivery Systems Market Overview by Route of Administration
6.6.3.3 Mexican Advanced Drug Delivery Systems Market Overview by Application

7. EUROPE
7.1 European Advanced Drug Delivery Systems Market Overview by Geographic Region
7.2 European Advanced Drug Delivery Systems Market Overview by Carrier Type
7.2.1 European Advanced Drug Delivery systems Carrier Type Market Overview by Geographic Region
7.2.1.1 Nanoparticles
7.2.1.2 Polymers
7.2.1.3 Monoclonal Antibodies
7.2.1.4 Other Carrier Types
7.3 European Advanced Drug Delivery Systems Market Overview by Route of Administration
7.3.1 European Advanced Drug Delivery systems Route of Administration Market Overview by Geographic Region
7.3.1.1 Oral
7.3.1.2 Parenteral
7.3.1.3 Topical
7.3.1.4 Other Routes of Administration
7.4 European Advanced Drug Delivery Systems Market Overview by Application
7.4.1 European Advanced Drug Delivery Systems Applications Market Overview by Geographic Region
7.4.1.1 Oncology
7.4.1.2 Cardiology
7.4.1.3 Neurology
7.4.1.4 Pulmonary
7.4.1.5 Other Applications
7.5 Major Market Players
Alkermes, Inc. (Ireland)
Astrazeneca PLC (United Kingdom)
Bayer AG (Germany)
Consort Medical PLC (United Kingdom)
Bespak Europe Ltd (United Kingdom)
Crossject (France)
European Pharma Group BV (The Netherlands)
Gerresheimer AG (Germany)
Injex UK Ltd (United Kingdom)
Sensile Medical AG (Switzerland)
Skyepharma Production SAS (France)

7.6 Country-wise Analysis of European Advanced Drug Delivery Systems Market
7.6.1 Germany
7.6.1.1 German Advanced Drug Delivery Systems Market Overview by Carrier Type
7.6.1.2 German Advanced Drug Delivery Systems Market Overview by Route of Administration
7.6.1.3 German Advanced Drug Delivery Systems Market Overview by Application

7.6.2 France
7.6.2.1 French Advanced Drug Delivery Systems Market Overview by Carrier Type
7.6.2.2 French Advanced Drug Delivery Systems Market Overview by Route of Administration
7.6.2.3 French Advanced Drug Delivery Systems Market Overview by Application

7.6.3 The United Kingdom
7.6.3.1 United Kingdom Advanced Drug Delivery Systems Market Overview by Carrier Type
7.6.3.2 United Kingdom Advanced Drug Delivery Systems Market Overview by Route of Administration
7.6.3.3 United Kingdom Advanced Drug Delivery Systems Market Overview by Application

7.6.4 Spain
7.6.4.1 Spanish Advanced Drug Delivery Systems Market Overview by Carrier Type
7.6.4.2 Spanish Advanced Drug Delivery Systems Market Overview by Route of Administration
7.6.4.3 Spanish Advanced Drug Delivery Systems Market Overview by Application

7.6.5 Italy
7.6.5.1 Italian Advanced Drug Delivery Systems Market Overview by Carrier Type
7.6.5.2 Italian Advanced Drug Delivery Systems Market Overview by Route of Administration
7.6.5.3 Italian Advanced Drug Delivery Systems Market Overview by Application

7.6.6 Rest of Europe
7.6.6.1 Rest of Europe Advanced Drug Delivery Systems Market Overview by Carrier Type
7.6.6.2 Rest of Europe Advanced Drug Delivery Systems Market Overview by Route of Administration
7.6.6.3 Rest of Europe Advanced Drug Delivery Systems Market Overview by Application

8. ASIA-PACIFIC
8.1 Asia-Pacific Advanced Drug Delivery Systems Market Overview by Geographic Region
8.2 Asia-Pacific Advanced Drug Delivery Systems Market Overview by Carrier Type
8.2.1 Asia-Pacific Advanced Drug Delivery systems Carrier Type Market Overview by Geographic Region
8.2.1.1 Nanoparticles
8.2.1.2 Polymers
8.2.1.3 Monoclonal Antibodies
8.2.1.4 Other Carrier Types
8.3 Asia-Pacific Advanced Drug Delivery Systems Market Overview by Route of Administration
8.3.1 Asia-Pacific Advanced Drug Delivery systems Route of Administration Market Overview by Geographic Region
8.3.1.1 Oral
8.3.1.2 Parenteral
8.3.1.3 Topical
8.3.1.4 Other Routes of Administration
8.4 Asia-Pacific Advanced Drug Delivery Systems Market Overview by Application
8.4.1 Asia-Pacific Advanced Drug Delivery Systems Applications Market Overview by Geographic Region
8.4.1.1 Oncology
8.4.1.2 Cardiology
8.4.1.3 Neurology
8.4.1.4 Pulmonary
8.4.1.5 Other Applications
8.5 Major Market Players
Hisamitsu Pharmaceutical Co., Inc. (Japan)
Kyoto Medical Planning Co., Ltd (Japan)
Lupin Ltd (India)
SHL Group (Taiwan)

8.6 Country-wise Analysis of Asia-Pacific Advanced Drug Delivery Systems Market
8.6.1 Japan
8.6.1.1 Japanese Advanced Drug Delivery Systems Market Overview by Carrier Type
8.6.1.2 Japanese Advanced Drug Delivery Systems Market Overview by Route of Administration
8.6.1.3 Japanese Advanced Drug Delivery Systems Market Overview by Application

8.6.2 China
8.6.2.1 Chinese Advanced Drug Delivery Systems Market Overview by Carrier Type
8.6.2.2 Chinese Advanced Drug Delivery Systems Market Overview by Route of Administration
8.6.2.3 Chinese Advanced Drug Delivery Systems Market Overview by Application

8.6.3 India
8.6.3.1 Indian Advanced Drug Delivery Systems Market Overview by Carrier Type
8.6.3.2 Indian Advanced Drug Delivery Systems Market Overview by Route of Administration
8.6.3.3 Indian Advanced Drug Delivery Systems Market Overview by Application

8.6.4 South Korea
8.6.4.1 South Korean Advanced Drug Delivery Systems Market Overview by Carrier Type
8.6.4.2 South Korean Advanced Drug Delivery Systems Market Overview by Route of Administration
8.6.4.3 South Korean Advanced Drug Delivery Systems Market Overview by Application

8.6.5 Rest of Asia-Pacific
8.6.5.1 Rest of Asia-Pacific Advanced Drug Delivery Systems Market Overview by Carrier Type
8.6.5.2 Rest of Asia-Pacific Advanced Drug Delivery Systems Market Overview by Route of Administration
8.6.5.3 Rest of Asia-Pacific Advanced Drug Delivery Systems Market Overview by Application

9. REST OF WORLD
9.1 Rest of World Advanced Drug Delivery Systems Market Overview by Geographic Region
9.2 Rest of World Advanced Drug Delivery Systems Market Overview by Carrier Type
9.2.1 Rest of World Advanced Drug Delivery systems Carrier Type Market Overview by Geographic Region
9.2.1.1 Nanoparticles
9.2.1.2 Polymers
9.2.1.3 Monoclonal Antibodies
9.2.1.4 Other Carrier Types
9.3 Rest of World Advanced Drug Delivery Systems Market Overview by Route of Administration
9.3.1 Rest of World Advanced Drug Delivery systems Route of Administration Market Overview by Geographic Region
9.3.1.1 Oral
9.3.1.2 Parenteral
9.3.1.3 Topical
9.3.1.4 Other Routes of Administration
9.4 Rest of World Advanced Drug Delivery Systems Market Overview by Application
9.4.1 Rest of World Advanced Drug Delivery Systems Applications Market Overview by Geographic Region
9.4.1.1 Oncology
9.4.1.2 Cardiology
9.4.1.3 Neurology
9.4.1.4 Pulmonary
9.4.1.5 Other Applications

9.5 Country-wise Analysis of Rest of World Advanced Drug Delivery Systems Market
9.5.1 Brazil
9.5.1.1 Brazilian Advanced Drug Delivery Systems Market Overview by Carrier Type
9.5.1.2 Brazilian Advanced Drug Delivery Systems Market Overview by Route of Administration
9.5.1.3 Brazilian Advanced Drug Delivery Systems Market Overview by Application

9.5.2 South Africa
9.5.2.1 South African Advanced Drug Delivery Systems Market Overview by Carrier Type
9.5.2.2 South African Advanced Drug Delivery Systems Market Overview by Route of Administration
9.5.2.3 South African Advanced Drug Delivery Systems Market Overview by Application

9.5.3 Other Countries
9.5.3.1 Other Countries Advanced Drug Delivery Systems Market Overview by Carrier Type
9.5.3.2 Other Countries Advanced Drug Delivery Systems Market Overview by Route of Administration
9.5.3.3 Other Countries Advanced Drug Delivery Systems Market Overview by Application

PART C: GUIDE TO THE INDUSTRY
1. NORTH AMERICA
2. EUROPE
3. ASIA-PACIFIC
4. REST OF WORLD

PART D: ANNEXURE
1. RESEARCH METHODOLOGY
2. FEEDBACK

Charts & Graphs

PART A: GLOBAL MARKET PERSPECTIVE

Chart 1: Global Advanced Drug Delivery Systems Market (2017 & 2024) by Carrier Type
Chart 2: Global Advanced Drug Delivery Systems Market (2017 & 2024) by Route of Administration
Chart 3: Global Advanced Drug Delivery Systems Market (2017 & 2024) by Application
Chart 4: Global Advanced Drug Delivery Systems Market Analysis (2015-2024) in USD Million
Chart 5: Global Advanced Drug Delivery Systems Market Analysis (2015-2024) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others in USD Million
Chart 6: Glance at 2015, 2017 and 2024 Global Advanced Drug Delivery Systems Market Share (%) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others
Chart 7: Global Market Analysis (2015-2024) for Nanoparticle-Based Advanced Drug Delivery Systems by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 8: Glance at 2015, 2017 and 2024 Global Market Share (%) for Nanoparticle-Based Advanced Drug Delivery Systems by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 9: Global Polymer Based Advanced Drug Delivery Systems Market Analysis (2015-2024) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 10: Glance at 2015, 2017 and 2024 Global Polymer Based Advanced Drug Delivery Systems Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 11: Global Market Analysis (2015-2024) for Monoclonal Antibodies as Advanced Drug Delivery Systems by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 12: Glance at 2015, 2017 and 2024 Global Market Share (%) for Monoclonal Antibodies as Advanced Drug Delivery Systems by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 13: Global Market Analysis (2015-2024) for Other Carrier-Based Advanced Drug Delivery Systems by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 14: Glance at 2015, 2017 and 2024 Global Market Share (%) for Other Carrier-Based Advanced Drug Delivery Systems by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 15: Global Advanced Drug Delivery Systems Market Analysis (2015-2024) by Route of Administration - Oral, Parenteral, Topical and Others in USD Million
Chart 16: Glance at 2015, 2017 and 2024 Global Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Parenteral, Topical and Others
Chart 17: Global Advanced Oral Drug Delivery Systems Market Analysis (2015-2024) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 18: Glance at 2015, 2017 and 2024 Global Advanced Oral Drug Delivery Systems Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 19: Global Advanced Parenteral Drug Delivery Systems Market Analysis (2015-2024) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 20: Glance at 2015, 2017 and 2024 Global Advanced Parenteral Drug Delivery Systems Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 21: Global Advanced Topical Drug Delivery Systems Market Analysis (2015-2024) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 22: Glance at 2015, 2017 and 2024 Global Advanced Topical Drug Delivery Systems Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 23: Global Other Advanced Drug Delivery Systems Routes of Administration Market Analysis (2015-2024) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 24: Glance at 2015, 2017 and 2024 Global Other Advanced Drug Delivery Systems Routes of Administration Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 25: Global Advanced Drug Delivery Systems Market Analysis (2015–2024) by Application – Oncology, Cardiology, Neurology, Pulmonary and Others in USD Million
Chart 26: Glance at 2015, 2017 and 2024 Global Advanced Drug Delivery Systems Market Share by Application – Oncology, Cardiology, Neurology, Pulmonary and Others
Chart 27: Global Advanced Drug Delivery Systems Market Analysis (2015–2024) in Oncology by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 28: Glance at 2015, 2017 and 2024 Global Advanced Drug Delivery Systems Market Share in Oncology by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 29: Global Advanced Drug Delivery Systems Market Analysis (2015–2024) in Cardiology by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 30: Glance at 2015, 2017 and 2024 Global Advanced Drug Delivery Systems Market Share in Cardiology by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 31: Global Advanced Drug Delivery Systems Market Analysis (2015–2024) in Neurology by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 32: Glance at 2015, 2017 and 2024 Global Advanced Drug Delivery Systems Market Share in Neurology by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 33: Global Advanced Drug Delivery Systems Market Analysis (2015–2024) in Pulmonary by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 34: Glance at 2015, 2017 and 2024 Global Advanced Drug Delivery Systems Market Share in Pulmonary by Geographic Region – North America, Europe, Asia-Pacific and Rest of World
Chart 35: Global Advanced Drug Delivery Systems Market Analysis (2015–2024) in Other Applications by Geographic Region – North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 36: Glance at 2015, 2017 and 2024 Global Advanced Drug Delivery Systems Market Share in Other Applications by Geographic Region – North America, Europe, Asia-Pacific and Rest of World

PART B: REGIONAL MARKET PERSPECTIVE
Chart 37: Global Advanced Drug Delivery Systems Market Analysis (2015–2024) by Geographic Region – North America, Europe, Asia - Pacific and Rest of World in USD Million
Chart 38: Glance at 2015, 2017 and 2024 Global Advanced Drug Delivery Systems Market Share by Geographic Region – North America, Europe, Asia - Pacific and Rest of World

REGIONAL MARKET OVERVIEW

NORTH AMERICA
Chart 39: North American Advanced Drug Delivery Systems Market Analysis (2015-2024) in USD Million
Chart 40: North American Advanced Drug Delivery Systems Market Analysis (2015-2024) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 41: Glance at 2015, 2017 and 2024 North American Advanced Drug Delivery Systems Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 42: North American Advanced Drug Delivery Systems Market Analysis (2015-2024) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others in USD Million
Chart 43: Glance at 2015, 2017 and 2024 North American Advanced Drug Delivery Systems Market Share (%) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others
Chart 44: North American Market Analysis (2015-2024) for Nanoparticle-Based Advanced Drug Delivery Systems by Geographic Region - United States, Canada and Mexico in USD Million
Chart 45: Glance at 2015, 2017 and 2024 North American Market Share (%) for Nanoparticle-Based Advanced Drug Delivery Systems by Geographic Region - United States, Canada and Mexico
Chart 46: North American Polymer Based Advanced Drug Delivery Systems Market Analysis (2015-2024) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 47: Glance at 2015, 2017 and 2024 North American Polymer Based Advanced Drug Delivery Systems Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 48: North American Market Analysis (2015-2024) for Monoclonal Antibodies as Advanced Drug Delivery Systems by Geographic Region - United States, Canada and Mexico in USD Million
Chart 49: Glance at 2015, 2017 and 2024 North American Market Share (%) for Monoclonal Antibodies as Advanced Drug Delivery Systems by Geographic Region - United States, Canada and Mexico
Chart 50: North American Market Analysis (2015-2024) for Other Carrier-Based Advanced Drug Delivery Systems by Geographic Region - United States, Canada and Mexico in USD Million
Chart 51: Glance at 2015, 2017 and 2024 North American Market Share (%) for Other Carrier-Based Advanced Drug Delivery Systems by Geographic Region - United States, Canada and Mexico
Chart 52: North American Advanced Drug Delivery Systems Market Analysis (2015-2024) by Route of Administration - Oral, Parenteral, Topical and Others in USD Million
Chart 53: Glance at 2015, 2017 and 2024 North American Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Parenteral, Topical and Others
Chart 54: North American Advanced Oral Drug Delivery Systems Market Analysis (2015-2024) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 55: Glance at 2015, 2017 and 2024 North American Advanced Oral Drug Delivery Systems Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 56: North American Advanced Parenteral Drug Delivery Systems Market Analysis (2015-2024) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 57: Glance at 2015, 2017 and 2024 North American Advanced Parenteral Drug Delivery Systems Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 58: North American Advanced Topical Drug Delivery Systems Market Analysis (2015-2024) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 59: Glance at 2015, 2017 and 2024 North American Advanced Topical Drug Delivery Systems Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 60: North American Other Advanced Drug Delivery Systems Routes of Administration Market Analysis (2015-2024) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 61: Glance at 2015, 2017 and 2024 North American Other Advanced Drug Delivery Systems Routes of Administration Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 62: North American Advanced Drug Delivery Systems Market Analysis (2015–2024) by Application – Oncology, Cardiology, Neurology, Pulmonary and Others in USD Million
Chart 63: Glance at 2015, 2017 and 2024 North American Advanced Drug Delivery Systems Market Share by Application – Oncology, Cardiology, Neurology, Pulmonary and Others
Chart 64: North American Advanced Drug Delivery Systems Market Analysis (2015–2024) in Oncology by Geographic Region – United States, Canada and Mexico in USD Million
Chart 65: Glance at 2015, 2017 and 2024 North American Advanced Drug Delivery Systems Market Share in Oncology by Geographic Region – United States, Canada and Mexico
Chart 66: North American Advanced Drug Delivery Systems Market Analysis (2015–2024) in Cardiology by Geographic Region – United States, Canada and Mexico in USD Million
Chart 67: Glance at 2015, 2017 and 2024 North American Advanced Drug Delivery Systems Market Share in Cardiology by Geographic Region – United States, Canada and Mexico
Chart 68: North American Advanced Drug Delivery Systems Market Analysis (2015–2024) in Neurology by Geographic Region – United States, Canada and Mexico in USD Million
Chart 69: Glance at 2015, 2017 and 2024 North American Advanced Drug Delivery Systems Market Share in Neurology by Geographic Region – United States, Canada and Mexico
Chart 70: North American Advanced Drug Delivery Systems Market Analysis (2015–2024) in Pulmonary by Geographic Region – United States, Canada and Mexico in USD Million
Chart 71: Glance at 2015, 2017 and 2024 North American Advanced Drug Delivery Systems Market Share in Pulmonary by Geographic Region – United States, Canada and Mexico
Chart 72: North American Advanced Drug Delivery Systems Market Analysis (2015–2024) in Other Applications by Geographic Region – United States, Canada and Mexico in USD Million
Chart 73: Glance at 2015, 2017 and 2024 North American Advanced Drug Delivery Systems Market Share in Other Applications by Geographic Region – United States, Canada and Mexico

The United States
Chart 74: United States Advanced Drug Delivery Systems Market Analysis (2015-2024) in USD Million
Chart 75: United States Advanced Drug Delivery Systems Market Analysis (2015-2024) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others in USD Million
Chart 76: Glance at 2015, 2017 and 2024 United States Advanced Drug Delivery Systems Market Share (%) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others
Chart 77: United States Advanced Drug Delivery Systems Market Analysis (2015-2024) by Route of Administration - Oral, Parenteral, Topical and Others in USD Million
Chart 78: Glance at 2015, 2017 and 2024 United States Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Parenteral, Topical and Others
Chart 79: United States Advanced Drug Delivery Systems Market Analysis (2015–2024) by Application – Oncology, Cardiology, Neurology, Pulmonary and Others in USD Million
Chart 80: Glance at 2015, 2017 and 2024 United States Advanced Drug Delivery Systems Market Share by Application – Oncology, Cardiology, Neurology, Pulmonary and Others

Canada
Chart 81: Canadian Advanced Drug Delivery Systems Market Analysis (2015-2024) in USD Million
Chart 82: Canadian Advanced Drug Delivery Systems Market Analysis (2015-2024) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others in USD Million
Chart 83: Glance at 2015, 2017 and 2024 Canadian Advanced Drug Delivery Systems Market Share (%) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others
Chart 84: Canadian Advanced Drug Delivery Systems Market Analysis (2015-2024) by Route of Administration - Oral, Parenteral, Topical and Others in USD Million
Chart 85: Glance at 2015, 2017 and 2024 Canadian Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Parenteral, Topical and Others
Chart 86: Canadian Advanced Drug Delivery Systems Market Analysis (2015–2024) by Application – Oncology, Cardiology, Neurology, Pulmonary and Others in USD Million
Chart 87: Glance at 2015, 2017 and 2024 Canadian Advanced Drug Delivery Systems Market Share by Application – Oncology, Cardiology, Neurology, Pulmonary and Others

Mexico
Chart 88: Mexican Advanced Drug Delivery Systems Market Analysis (2015-2024) in USD Million
Chart 89: Mexican Advanced Drug Delivery Systems Market Analysis (2015-2024) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others in USD Million
Chart 90: Glance at 2015, 2017 and 2024 Mexican Advanced Drug Delivery Systems Market Share (%) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others
Chart 91: Mexican Advanced Drug Delivery Systems Market Analysis (2015-2024) by Route of Administration - Oral, Parenteral, Topical and Others in USD Million
Chart 92: Glance at 2015, 2017 and 2024 Mexican Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Parenteral, Topical and Others
Chart 93: Mexican Advanced Drug Delivery Systems Market Analysis (2015–2024) by Application – Oncology, Cardiology, Neurology, Pulmonary and Others in USD Million
Chart 94: Glance at 2015, 2017 and 2024 Mexican Advanced Drug Delivery Systems Market Share by Application – Oncology, Cardiology, Neurology, Pulmonary and Others

EUROPE
Chart 95: European Advanced Drug Delivery Systems Market Analysis (2015-2024) in USD Million
Chart 96: European Advanced Drug Delivery Systems Market Analysis (2015-2024) by Geographic Region - Germany, France, United Kingdom, Spain, Italy and Rest of Europe in USD Million
Chart 97: Glance at 2015, 2017 and 2024 European Advanced Drug Delivery Systems Market Share (%) by Geographic Region - Germany, France, United Kingdom, Spain, Italy and Rest of Europe
Chart 98: European Advanced Drug Delivery Systems Market Analysis (2015-2024) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others in USD Million
Chart 99: Glance at 2015, 2017 and 2024 European Advanced Drug Delivery Systems Market Share (%) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others
Chart 100: European Market Analysis (2015-2024) for Nanoparticle-Based Advanced Drug Delivery Systems by Geographic Region - Germany, France, United Kingdom, Spain, Italy and Rest of Europe in USD Million
Chart 101: Glance at 2015, 2017 and 2024 European Market Share (%) for Nanoparticle-Based Advanced Drug Delivery Systems by Geographic Region - Germany, France, United Kingdom, Spain, Italy and Rest of Europe
Chart 102: European Polymer Based Advanced Drug Delivery Systems Market Analysis (2015-2024) by Geographic Region - Germany, France, United Kingdom, Spain, Italy and Rest of Europe in USD Million
Chart 103: Glance at 2015, 2017 and 2024 European Polymer Based Advanced Drug Delivery Systems Market Share (%) by Geographic Region - Germany, France, United Kingdom, Spain, Italy and Rest of Europe
Chart 104: European Market Analysis (2015-2024) for Monoclonal Antibodies as Advanced Drug Delivery Systems by Geographic Region - Germany, France, United Kingdom, Spain, Italy and Rest of Europe in USD Million
Chart 105: Glance at 2015, 2017 and 2024 European Market Share (%) for Monoclonal Antibodies as Advanced Drug Delivery Systems by Geographic Region - Germany, France, United Kingdom, Spain, Italy and Rest of Europe
Chart 106: European Market Analysis (2015-2024) for Other Carrier-Based Advanced Drug Delivery Systems by Geographic Region - Germany, France, United Kingdom, Spain, Italy and Rest of Europe in USD Million
Chart 107: Glance at 2015, 2017 and 2024 European Market Share (%) for Other Carrier-Based Advanced Drug Delivery Systems by Geographic Region - Germany, France, United Kingdom, Spain, Italy and Rest of Europe
Chart 108: European Advanced Drug Delivery Systems Market Analysis (2015-2024) by Route of Administration - Oral, Parenteral, Topical and Others in USD Million
Chart 109: Glance at 2015, 2017 and 2024 European Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Parenteral, Topical and Others
Chart 110: European Advanced Oral Drug Delivery Systems Market Analysis (2015-2024) by Geographic Region - Germany, France, United Kingdom, Spain, Italy and Rest of Europe in USD Million
Chart 111: Glance at 2015, 2017 and 2024 European Advanced Oral Drug Delivery Systems Market Share (%) by Geographic Region - Germany, France, United Kingdom, Spain, Italy and Rest of Europe
Chart 112: European Advanced Parenteral Drug Delivery Systems Market Analysis (2015-2024) by Geographic Region - Germany, France, United Kingdom, Spain, Italy and Rest of Europe in USD Million
Chart 113: Glance at 2015, 2017 and 2024 European Advanced Parenteral Drug Delivery Systems Market Share (%) by Geographic Region - Germany, France, United Kingdom, Spain, Italy and Rest of Europe
Chart 114: European Advanced Topical Drug Delivery Systems Market Analysis (2015-2024) by Geographic Region - Germany, France, United Kingdom, Spain, Italy and Rest of Europe in USD Million
Chart 115: Glance at 2015, 2017 and 2024 European Advanced Topical Drug Delivery Systems Market Share (%) by Geographic Region - Germany, France, United Kingdom, Spain, Italy and Rest of Europe
Chart 116: European Other Advanced Drug Delivery Systems Routes of Administration Market Analysis (2015-2024) by Geographic Region - Germany, France, United Kingdom, Spain, Italy and Rest of Europe in USD Million
Chart 117: Glance at 2015, 2017 and 2024 European Other Advanced Drug Delivery Systems Routes of Administration Market Share (%) by Geographic Region - Germany, France, United Kingdom, Spain, Italy and Rest of Europe
Chart 118: European Advanced Drug Delivery Systems Market Analysis (2015–2024) by Application – Oncology, Cardiology, Neurology, Pulmonary and Others in USD Million
Chart 119: Glance at 2015, 2017 and 2024 European Advanced Drug Delivery Systems Market Share by Application – Oncology, Cardiology, Neurology, Pulmonary and Others
Chart 120: European Advanced Drug Delivery Systems Market Analysis (2015–2024) in Oncology by Geographic Region – Germany, France, United Kingdom, Spain, Italy and Rest of Europe in USD Million
Chart 121: Glance at 2015, 2017 and 2024 European Advanced Drug Delivery Systems Market Share in Oncology by Geographic Region – Germany, France, United Kingdom, Spain, Italy and Rest of Europe
Chart 122: European Advanced Drug Delivery Systems Market Analysis (2015–2024) in Cardiology by Geographic Region – Germany, France, United Kingdom, Spain, Italy and Rest of Europe in USD Million
Chart 123: Glance at 2015, 2017 and 2024 European Advanced Drug Delivery Systems Market Share in Cardiology by Geographic Region – Germany, France, United Kingdom, Spain, Italy and Rest of Europe
Chart 124: European Advanced Drug Delivery Systems Market Analysis (2015–2024) in Neurology by Geographic Region – Germany, France, United Kingdom, Spain, Italy and Rest of Europe in USD Million
Chart 125: Glance at 2015, 2017 and 2024 European Advanced Drug Delivery Systems Market Share in Neurology by Geographic Region – Germany, France, United Kingdom, Spain, Italy and Rest of Europe
Chart 126: European Advanced Drug Delivery Systems Market Analysis (2015–2024) in Pulmonary by Geographic Region – Germany, France, United Kingdom, Spain, Italy and Rest of Europe in USD Million
Chart 127: Glance at 2015, 2017 and 2024 European Advanced Drug Delivery Systems Market Share in Pulmonary by Geographic Region – Germany, France, United Kingdom, Spain, Italy and Rest of Europe
Chart 128: European Advanced Drug Delivery Systems Market Analysis (2015–2024) in Other Applications by Geographic Region – Germany, France, United Kingdom, Spain, Italy and Rest of Europe in USD Million
Chart 129: Glance at 2015, 2017 and 2024 European Advanced Drug Delivery Systems Market Share in Other Applications by Geographic Region – Germany, France, United Kingdom, Spain, Italy and Rest of Europe

Germany
Chart 130: German Advanced Drug Delivery Systems Market Analysis (2015-2024) in USD Million
Chart 131: German Advanced Drug Delivery Systems Market Analysis (2015-2024) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others in USD Million
Chart 132: Glance at 2015, 2017 and 2024 German Advanced Drug Delivery Systems Market Share (%) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others
Chart 133: German Advanced Drug Delivery Systems Market Analysis (2015-2024) by Route of Administration - Oral, Parenteral, Topical and Others in USD Million
Chart 134: Glance at 2015, 2017 and 2024 German Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Parenteral, Topical and Others
Chart 135: German Advanced Drug Delivery Systems Market Analysis (2015–2024) by Application – Oncology, Cardiology, Neurology, Pulmonary and Others in USD Million
Chart 136: Glance at 2015, 2017 and 2024 German Advanced Drug Delivery Systems Market Share by Application – Oncology, Cardiology, Neurology, Pulmonary and Others

France
Chart 137: French Advanced Drug Delivery Systems Market Analysis (2015-2024) in USD Million
Chart 138: French Advanced Drug Delivery Systems Market Analysis (2015-2024) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others in USD Million
Chart 139: Glance at 2015, 2017 and 2024 French Advanced Drug Delivery Systems Market Share (%) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others
Chart 140: French Advanced Drug Delivery Systems Market Analysis (2015-2024) by Route of Administration - Oral, Parenteral, Topical and Others in USD Million
Chart 141: Glance at 2015, 2017 and 2024 French Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Parenteral, Topical and Others
Chart 142: French Advanced Drug Delivery Systems Market Analysis (2015–2024) by Application – Oncology, Cardiology, Neurology, Pulmonary and Others in USD Million
Chart 143: Glance at 2015, 2017 and 2024 French Advanced Drug Delivery Systems Market Share by Application – Oncology, Cardiology, Neurology, Pulmonary and Others

The United Kingdom
Chart 144: United Kingdom Advanced Drug Delivery Systems Market Analysis (2015-2024) in USD Million
Chart 145: United Kingdom Advanced Drug Delivery Systems Market Analysis (2015-2024) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others in USD Million
Chart 146: Glance at 2015, 2017 and 2024 United Kingdom Advanced Drug Delivery Systems Market Share (%) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others
Chart 147: United Kingdom Advanced Drug Delivery Systems Market Analysis (2015-2024) by Route of Administration - Oral, Parenteral, Topical and Others in USD Million
Chart 148: Glance at 2015, 2017 and 2024 United Kingdom Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Parenteral, Topical and Others
Chart 149: United Kingdom Advanced Drug Delivery Systems Market Analysis (2015–2024) by Application – Oncology, Cardiology, Neurology, Pulmonary and Others in USD Million
Chart 150: Glance at 2015, 2017 and 2024 United Kingdom Advanced Drug Delivery Systems Market Share by Application – Oncology, Cardiology, Neurology, Pulmonary and Others

Spain
Chart 151: Spanish Advanced Drug Delivery Systems Market Analysis (2015-2024) in USD Million
Chart 152: Spanish Advanced Drug Delivery Systems Market Analysis (2015-2024) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Otherf`s in USD Million
Chart 153: Glance at 2015, 2017 and 2024 Spanish Advanced Drug Delivery Systems Market Share (%) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others
Chart 154: Spanish Advanced Drug Delivery Systems Market Analysis (2015-2024) by Route of Administration - Oral, Parenteral, Topical and Others in USD Million
Chart 155: Glance at 2015, 2017 and 2024 Spanish Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Parenteral, Topical and Others
Chart 156: Spanish Advanced Drug Delivery Systems Market Analysis (2015–2024) by Application – Oncology, Cardiology, Neurology, Pulmonary and Others in USD Million
Chart 157: Glance at 2015, 2017 and 2024 Spanish Advanced Drug Delivery Systems Market Share by Application – Oncology, Cardiology, Neurology, Pulmonary and Others

Italy
Chart 158: Italian Advanced Drug Delivery Systems Market Analysis (2015-2024) in USD Million
Chart 159: Italian Advanced Drug Delivery Systems Market Analysis (2015-2024) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others in USD Million
Chart 160: Glance at 2015, 2017 and 2024 Italian Advanced Drug Delivery Systems Market Share (%) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others
Chart 161: Italian Advanced Drug Delivery Systems Market Analysis (2015-2024) by Route of Administration - Oral, Parenteral, Topical and Others in USD Million
Chart 162: Glance at 2015, 2017 and 2024 Italian Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Parenteral, Topical and Others
Chart 163: Italian Advanced Drug Delivery Systems Market Analysis (2015–2024) by Application – Oncology, Cardiology, Neurology, Pulmonary and Others in USD Million
Chart 164: Glance at 2015, 2017 and 2024 Italian Advanced Drug Delivery Systems Market Share by Application – Oncology, Cardiology, Neurology, Pulmonary and Others

Rest of Europe
Chart 165: Rest of Europe Advanced Drug Delivery Systems Market Analysis (2015-2024) in USD Million
Chart 166: Rest of Europe Advanced Drug Delivery Systems Market Analysis (2015-2024) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others in USD Million
Chart 167: Glance at 2015, 2017 and 2024 Rest of Europe Advanced Drug Delivery Systems Market Share (%) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others
Chart 168: Rest of Europe Advanced Drug Delivery Systems Market Analysis (2015-2024) by Route of Administration - Oral, Parenteral, Topical and Others in USD Million
Chart 169: Glance at 2015, 2017 and 2024 Rest of Europe Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Parenteral, Topical and Others
Chart 170: Rest of Europe Advanced Drug Delivery Systems Market Analysis (2015–2024) by Application – Oncology, Cardiology, Neurology, Pulmonary and Others in USD Million
Chart 171: Glance at 2015, 2017 and 2024 Rest of Europe Advanced Drug Delivery Systems Market Share by Application – Oncology, Cardiology, Neurology, Pulmonary and Others

ASIA-PACIFIC
Chart 172: Asia-Pacific Advanced Drug Delivery Systems Market Analysis (2015-2024) in USD Million
Chart 173: Asia-Pacific Advanced Drug Delivery Systems Market Analysis (2015-2024) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 174: Glance at 2015, 2017 and 2024 Asia-Pacific Advanced Drug Delivery Systems Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 175: Asia-Pacific Advanced Drug Delivery Systems Market Analysis (2015-2024) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others in USD Million
Chart 176: Glance at 2015, 2017 and 2024 Asia-Pacific Advanced Drug Delivery Systems Market Share (%) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others
Chart 177: Asia-Pacific Market Analysis (2015-2024) for Nanoparticle-Based Advanced Drug Delivery Systems by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 178: Glance at 2015, 2017 and 2024 Asia-Pacific Market Share (%) for Nanoparticle-Based Advanced Drug Delivery Systems by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 179: Asia-Pacific Polymer Based Advanced Drug Delivery Systems Market Analysis (2015-2024) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 180: Glance at 2015, 2017 and 2024 Asia-Pacific Polymer Based Advanced Drug Delivery Systems Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 181: Asia-Pacific Market Analysis (2015-2024) for Monoclonal Antibodies as Advanced Drug Delivery Systems by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 182: Glance at 2015, 2017 and 2024 Asia-Pacific Market Share (%) for Monoclonal Antibodies as Advanced Drug Delivery Systems by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 183: Asia-Pacific Market Analysis (2015-2024) for Other Carrier-Based Advanced Drug Delivery Systems by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 184: Glance at 2015, 2017 and 2024 Asia-Pacific Market Share (%) for Other Carrier-Based Advanced Drug Delivery Systems by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 185: Asia-Pacific Advanced Drug Delivery Systems Market Analysis (2015-2024) by Route of Administration - Oral, Parenteral, Topical and Others in USD Million
Chart 186: Glance at 2015, 2017 and 2024 Asia-Pacific Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Parenteral, Topical and Others
Chart 187: Asia-Pacific Advanced Oral Drug Delivery Systems Market Analysis (2015-2024) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 188: Glance at 2015, 2017 and 2024 Asia-Pacific Advanced Oral Drug Delivery Systems Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 189: Asia-Pacific Advanced Parenteral Drug Delivery Systems Market Analysis (2015-2024) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 190: Glance at 2015, 2017 and 2024 Asia-Pacific Advanced Parenteral Drug Delivery Systems Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 191: Asia-Pacific Advanced Topical Drug Delivery Systems Market Analysis (2015-2024) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 192: Glance at 2015, 2017 and 2024 Asia-Pacific Advanced Topical Drug Delivery Systems Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 193: Asia-Pacific Other Advanced Drug Delivery Systems Routes of Administration Market Analysis (2015-2024) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 194: Glance at 2015, 2017 and 2024 Asia-Pacific Other Advanced Drug Delivery Systems Routes of Administration Market Share (%) by Geographic Region - Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 195: Asia-Pacific Advanced Drug Delivery Systems Market Analysis (2015–2024) by Application – Oncology, Cardiology, Neurology, Pulmonary and Others in USD Million
Chart 196: Glance at 2015, 2017 and 2024 Asia-Pacific Advanced Drug Delivery Systems Market Share by Application – Oncology, Cardiology, Neurology, Pulmonary and Others
Chart 197: Asia-Pacific Advanced Drug Delivery Systems Market Analysis (2015–2024) in Oncology by Geographic Region – Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 198: Glance at 2015, 2017 and 2024 Asia-Pacific Advanced Drug Delivery Systems Market Share in Oncology by Geographic Region – Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 199: Asia-Pacific Advanced Drug Delivery Systems Market Analysis (2015–2024) in Cardiology by Geographic Region – Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 200: Glance at 2015, 2017 and 2024 Asia-Pacific Advanced Drug Delivery Systems Market Share in Cardiology by Geographic Region – Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 201: Asia-Pacific Advanced Drug Delivery Systems Market Analysis (2015–2024) in Neurology by Geographic Region – Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 202: Glance at 2015, 2017 and 2024 Asia-Pacific Advanced Drug Delivery Systems Market Share in Neurology by Geographic Region – Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 203: Asia-Pacific Advanced Drug Delivery Systems Market Analysis (2015–2024) in Pulmonary by Geographic Region – Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 204: Glance at 2015, 2017 and 2024 Asia-Pacific Advanced Drug Delivery Systems Market Share in Pulmonary by Geographic Region – Japan, China, India, South Korea and Rest of Asia-Pacific
Chart 205: Asia-Pacific Advanced Drug Delivery Systems Market Analysis (2015–2024) in Other Applications by Geographic Region – Japan, China, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 206: Glance at 2015, 2017 and 2024 Asia-Pacific Advanced Drug Delivery Systems Market Share in Other Applications by Geographic Region – Japan, China, India, South Korea and Rest of Asia-Pacific

Japan
Chart 207: Japanese Advanced Drug Delivery Systems Market Analysis (2015-2024) in USD Million
Chart 208: Japanese Advanced Drug Delivery Systems Market Analysis (2015-2024) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others in USD Million
Chart 209: Glance at 2015, 2017 and 2024 Japanese Advanced Drug Delivery Systems Market Share (%) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others
Chart 210: Japanese Advanced Drug Delivery Systems Market Analysis (2015-2024) by Route of Administration - Oral, Parenteral, Topical and Others in USD Million
Chart 211: Glance at 2015, 2017 and 2024 Japanese Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Parenteral, Topical and Others
Chart 212: Japanese Advanced Drug Delivery Systems Market Analysis (2015–2024) by Application – Oncology, Cardiology, Neurology, Pulmonary and Others in USD Million
Chart 213: Glance at 2015, 2017 and 2024 Japanese Advanced Drug Delivery Systems Market Share by Application – Oncology, Cardiology, Neurology, Pulmonary and Others

China
Chart 214: Chinese Advanced Drug Delivery Systems Market Analysis (2015-2024) in USD Million
Chart 215: Chinese Advanced Drug Delivery Systems Market Analysis (2015-2024) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others in USD Million
Chart 216: Glance at 2015, 2017 and 2024 Chinese Advanced Drug Delivery Systems Market Share (%) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others
Chart 217: Chinese Advanced Drug Delivery Systems Market Analysis (2015-2024) by Route of Administration - Oral, Parenteral, Topical and Others in USD Million
Chart 218: Glance at 2015, 2017 and 2024 Chinese Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Parenteral, Topical and Others
Chart 219: Chinese Advanced Drug Delivery Systems Market Analysis (2015–2024) by Application – Oncology, Cardiology, Neurology, Pulmonary and Others in USD Million
Chart 220: Glance at 2015, 2017 and 2024 Chinese Advanced Drug Delivery Systems Market Share by Application – Oncology, Cardiology, Neurology, Pulmonary and Others

India
Chart 221: Indian Advanced Drug Delivery Systems Market Analysis (2015-2024) in USD Million
Chart 222: Indian Advanced Drug Delivery Systems Market Analysis (2015-2024) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others in USD Million
Chart 223: Glance at 2015, 2017 and 2024 Indian Advanced Drug Delivery Systems Market Share (%) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others
Chart 224: Indian Advanced Drug Delivery Systems Market Analysis (2015-2024) by Route of Administration - Oral, Parenteral, Topical and Others in USD Million
Chart 225: Glance at 2015, 2017 and 2024 Indian Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Parenteral, Topical and Others
Chart 226: Indian Advanced Drug Delivery Systems Market Analysis (2015–2024) by Application – Oncology, Cardiology, Neurology, Pulmonary and Others in USD Million
Chart 227: Glance at 2015, 2017 and 2024 Indian Advanced Drug Delivery Systems Market Share by Application – Oncology, Cardiology, Neurology, Pulmonary and Others

South Korea
Chart 228: South Korean Advanced Drug Delivery Systems Market Analysis (2015-2024) in USD Million
Chart 229: South Korean Advanced Drug Delivery Systems Market Analysis (2015-2024) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others in USD Million
Chart 230: Glance at 2015, 2017 and 2024 South Korean Advanced Drug Delivery Systems Market Share (%) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others
Chart 231: South Korean Advanced Drug Delivery Systems Market Analysis (2015-2024) by Route of Administration - Oral, Parenteral, Topical and Others in USD Million
Chart 232: Glance at 2015, 2017 and 2024 South Korean Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Parenteral, Topical and Others
Chart 233: South Korean Advanced Drug Delivery Systems Market Analysis (2015–2024) by Application – Oncology, Cardiology, Neurology, Pulmonary and Others in USD Million
Chart 234: Glance at 2015, 2017 and 2024 South Korean Advanced Drug Delivery Systems Market Share by Application – Oncology, Cardiology, Neurology, Pulmonary and Others

Rest of Asia-Pacific
Chart 235: Rest of Asia-Pacific Advanced Drug Delivery Systems Market Analysis (2015-2024) in USD Million
Chart 236: Rest of Asia-Pacific Advanced Drug Delivery Systems Market Analysis (2015-2024) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others in USD Million
Chart 237: Glance at 2015, 2017 and 2024 Rest of Asia-Pacific Advanced Drug Delivery Systems Market Share (%) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others
Chart 238: Rest of Asia-Pacific Advanced Drug Delivery Systems Market Analysis (2015-2024) by Route of Administration - Oral, Parenteral, Topical and Others in USD Million
Chart 239: Glance at 2015, 2017 and 2024 Rest of Asia-Pacific Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Parenteral, Topical and Others
Chart 240: Rest of Asia-Pacific Advanced Drug Delivery Systems Market Analysis (2015–2024) by Application – Oncology, Cardiology, Neurology, Pulmonary and Others in USD Million
Chart 241: Glance at 2015, 2017 and 2024 Rest of Asia-Pacific Advanced Drug Delivery Systems Market Share by Application – Oncology, Cardiology, Neurology, Pulmonary and Others

REST OF WORLD
Chart 242: Rest of World Advanced Drug Delivery Systems Market Analysis (2015-2024) in USD Million
Chart 243: Rest of World Advanced Drug Delivery Systems Market Analysis (2015-2024) by Geographic Region - Brazil, South Africa and Other Countries in USD Million
Chart 244: Glance at 2015, 2017 and 2024 Rest of World Advanced Drug Delivery Systems Market Share (%) by Geographic Region - Brazil, South Africa and Other Countries
Chart 245: Rest of World Advanced Drug Delivery Systems Market Analysis (2015-2024) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others in USD Million
Chart 246: Glance at 2015, 2017 and 2024 Rest of World Advanced Drug Delivery Systems Market Share (%) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others
Chart 247: Rest of World Market Analysis (2015-2024) for Nanoparticle-Based Advanced Drug Delivery Systems by Geographic Region - Brazil, South Africa and Other Countries in USD Million
Chart 248: Glance at 2015, 2017 and 2024 Rest of World Market Share (%) for Nanoparticle-Based Advanced Drug Delivery Systems by Geographic Region - Brazil, South Africa and Other Countries
Chart 249: Rest of World Polymer Based Advanced Drug Delivery Systems Market Analysis (2015-2024) by Geographic Region - Brazil, South Africa and Other Countries in USD Million
Chart 250: Glance at 2015, 2017 and 2024 Rest of World Polymer Based Advanced Drug Delivery Systems Market Share (%) by Geographic Region - Brazil, South Africa and Other Countries
Chart 251: Rest of World Market Analysis (2015-2024) for Monoclonal Antibodies as Advanced Drug Delivery Systems by Geographic Region - Brazil, South Africa and Other Countries in USD Million
Chart 252: Glance at 2015, 2017 and 2024 Rest of World Market Share (%) for Monoclonal Antibodies as Advanced Drug Delivery Systems by Geographic Region - Brazil, South Africa and Other Countries
Chart 253: Rest of World Market Analysis (2015-2024) for Other Carrier-Based Advanced Drug Delivery Systems by Geographic Region - Brazil, South Africa and Other Countries in USD Million
Chart 254: Glance at 2015, 2017 and 2024 Rest of World Market Share (%) for Other Carrier-Based Advanced Drug Delivery Systems by Geographic Region - Brazil, South Africa and Other Countries
Chart 255: Rest of World Advanced Drug Delivery Systems Market Analysis (2015-2024) by Route of Administration - Oral, Parenteral, Topical and Others in USD Million
Chart 256: Glance at 2015, 2017 and 2024 Rest of World Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Parenteral, Topical and Others
Chart 257: Rest of World Advanced Oral Drug Delivery Systems Market Analysis (2015-2024) by Geographic Region - Brazil, South Africa and Other Countries in USD Million
Chart 258: Glance at 2015, 2017 and 2024 Rest of World Advanced Oral Drug Delivery Systems Market Share (%) by Geographic Region - Brazil, South Africa and Other Countries
Chart 259: Rest of World Advanced Parenteral Drug Delivery Systems Market Analysis (2015-2024) by Geographic Region - Brazil, South Africa and Other Countries in USD Million
Chart 260: Glance at 2015, 2017 and 2024 Rest of World Advanced Parenteral Drug Delivery Systems Market Share (%) by Geographic Region - Brazil, South Africa and Other Countries
Chart 261: Rest of World Advanced Topical Drug Delivery Systems Market Analysis (2015-2024) by Geographic Region - Brazil, South Africa and Other Countries in USD Million
Chart 262: Glance at 2015, 2017 and 2024 Rest of World Advanced Topical Drug Delivery Systems Market Share (%) by Geographic Region - Brazil, South Africa and Other Countries
Chart 263: Rest of World Other Advanced Drug Delivery Systems Routes of Administration Market Analysis (2015-2024) by Geographic Region - Brazil, South Africa and Other Countries in USD Million
Chart 264: Glance at 2015, 2017 and 2024 Rest of World Other Advanced Drug Delivery Systems Routes of Administration Market Share (%) by Geographic Region - Brazil, South Africa and Other Countries
Chart 265: Rest of World Advanced Drug Delivery Systems Market Analysis (2015–2024) by Application – Oncology, Cardiology, Neurology, Pulmonary and Others in USD Million
Chart 266: Glance at 2015, 2017 and 2024 Rest of World Advanced Drug Delivery Systems Market Share by Application – Oncology, Cardiology, Neurology, Pulmonary and Others
Chart 267: Rest of World Advanced Drug Delivery Systems Market Analysis (2015–2024) in Oncology by Geographic Region – Brazil, South Africa and Other Countries in USD Million
Chart 268: Glance at 2015, 2017 and 2024 Rest of World Advanced Drug Delivery Systems Market Share in Oncology by Geographic Region – Brazil, South Africa and Other Countries
Chart 269: Rest of World Advanced Drug Delivery Systems Market Analysis (2015–2024) in Cardiology by Geographic Region – Brazil, South Africa and Other Countries in USD Million
Chart 270: Glance at 2015, 2017 and 2024 Rest of World Advanced Drug Delivery Systems Market Share in Cardiology by Geographic Region – Brazil, South Africa and Other Countries
Chart 271: Rest of World Advanced Drug Delivery Systems Market Analysis (2015–2024) in Neurology by Geographic Region – Brazil, South Africa and Other Countries in USD Million
Chart 272: Glance at 2015, 2017 and 2024 Rest of World Advanced Drug Delivery Systems Market Share in Neurology by Geographic Region – Brazil, South Africa and Other Countries
Chart 273: Rest of World Advanced Drug Delivery Systems Market Analysis (2015–2024) in Pulmonary by Geographic Region – Brazil, South Africa and Other Countries in USD Million
Chart 274: Glance at 2015, 2017 and 2024 Rest of World Advanced Drug Delivery Systems Market Share in Pulmonary by Geographic Region – Brazil, South Africa and Other Countries
Chart 275: Rest of World Advanced Drug Delivery Systems Market Analysis (2015–2024) in Other Applications by Geographic Region – Brazil, South Africa and Other Countries in USD Million
Chart 276: Glance at 2015, 2017 and 2024 Rest of World Advanced Drug Delivery Systems Market Share in Other Applications by Geographic Region – Brazil, South Africa and Other Countries

Brazil
Chart 277: Brazilian Advanced Drug Delivery Systems Market Analysis (2015-2024) in USD Million
Chart 278: Brazilian Advanced Drug Delivery Systems Market Analysis (2015-2024) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others in USD Million
Chart 279: Glance at 2015, 2017 and 2024 Brazilian Advanced Drug Delivery Systems Market Share (%) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others
Chart 280: Brazilian Advanced Drug Delivery Systems Market Analysis (2015-2024) by Route of Administration - Oral, Parenteral, Topical and Others in USD Million
Chart 281: Glance at 2015, 2017 and 2024 Brazilian Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Parenteral, Topical and Others
Chart 282: Brazilian Advanced Drug Delivery Systems Market Analysis (2015–2024) by Application – Oncology, Cardiology, Neurology, Pulmonary and Others in USD Million
Chart 283: Glance at 2015, 2017 and 2024 Brazilian Advanced Drug Delivery Systems Market Share by Application – Oncology, Cardiology, Neurology, Pulmonary and Others

South Africa
Chart 284: South African Advanced Drug Delivery Systems Market Analysis (2015-2024) in USD Million
Chart 285: South African Advanced Drug Delivery Systems Market Analysis (2015-2024) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others in USD Million
Chart 286: Glance at 2015, 2017 and 2024 South African Advanced Drug Delivery Systems Market Share (%) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others
Chart 287: South African Advanced Drug Delivery Systems Market Analysis (2015-2024) by Route of Administration - Oral, Parenteral, Topical and Others in USD Million
Chart 288: Glance at 2015, 2017 and 2024 South African Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Parenteral, Topical and Others
Chart 289: South African Advanced Drug Delivery Systems Market Analysis (2015–2024) by Application – Oncology, Cardiology, Neurology, Pulmonary and Others in USD Million
Chart 290: Glance at 2015, 2017 and 2024 South African Advanced Drug Delivery Systems Market Share by Application – Oncology, Cardiology, Neurology, Pulmonary and Others

Other Countries
Chart 291: Other Countries Advanced Drug Delivery Systems Market Analysis (2015-2024) in USD Million
Chart 292: Other Countries Advanced Drug Delivery Systems Market Analysis (2015-2024) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others in USD Million
Chart 293: Glance at 2015, 2017 and 2024 Other Countries Advanced Drug Delivery Systems Market Share (%) by Carrier Type - Nanoparticles, Polymers, Monoclonal Antibodies and Others
Chart 294: Other Countries Advanced Drug Delivery Systems Market Analysis (2015-2024) by Route of Administration - Oral, Parenteral, Topical and Others in USD Million
Chart 295: Glance at 2015, 2017 and 2024 Other Countries Advanced Drug Delivery Systems Market Share (%) by Route of Administration - Oral, Parenteral, Topical and Others
Chart 296: Other Countries Advanced Drug Delivery Systems Market Analysis (2015–2024) by Application – Oncology, Cardiology, Neurology, Pulmonary and Others in USD Million
Chart 297: Glance at 2015, 2017 and 2024 Other Countries Advanced Drug Delivery Systems Market Share by Application – Oncology, Cardiology, Neurology, Pulmonary and Others

3M Company
Adare Pharmaceuticals, Inc
Alkermes, Inc.
Astrazeneca PLC
Bayer AG
Becton, Dickinson and Company
Capsugel, Inc.
Catalent, Inc.
Consort Medical PLC
Elixir Medical Corporation
Gerresheimer AG
Hisamitsu Pharmaceutical Co., Inc.
HNS International, Inc.
Insulet Corporation
Lupin Ltd
Nektar Therapeutics
Novavax, Inc.
SHL Group

PLEASE SELECT LICENSE TYPE

Have a question
About this report?

EMAIL US

Subscribe to Newsletter
for all latest updates

SUBSCRIBE

RELATED REPORTS

ph017-global-carotenoids-market-products-and-applications

Global Carotenoids Market – Products and Applications
Report Code: PH017 | Pages: 344 | Price: $4050

Published
Aug 2018

ph009-global-astaxanthin-market-sources-technologies-and-applications

Global Astaxanthin Market – Sources, Technologies and Applications
Report Code: PH009 | Pages: 292 | Price: $4500

Published
Aug 2018

hc014-biopsy-devices-a-global-market-overview

Biopsy Devices – A Global Market Overview
Report Code: HC014 | Pages: 380 | Price: $4500

Published
Jun 2018

hc016-endoscopy-devices-a-global-market-overview

Endoscopy Devices – A Global Market Overview
Report Code: HC016 | Pages: 370 | Price: $4050

Published
Apr 2018